Live Breaking News & Updates on Protembis Gmbh

Stay updated with breaking news from Protembis gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Unveiling Growth Trends in the 14% CAGR TAVR Embolic Protection Market

Unveiling Growth Trends in the 14% CAGR TAVR Embolic Protection Market
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Saudi Arabia , United Kingdom , United States , South Africa , South Korea , David Correa , Pawan Kumar , Protembis Gmbh , Venus Medtech Hangzhou Inc , Top Leading Key Companies , Boston Scientific Corporation , Innovative Cardiovascular Solutions , Transverse Medical Inc , Business Intelligence Solutions , Emboline Inc , Market Research , Edward Lifesciences Corporation , Filterlex Medical Ltd , Strategic Development , Technologies Inc , Protection Marketby Product , Global Opportunity Analysis , Industry Forecast , Market Size , Growing Region ,

Protembis GmbH: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

Protembis GmbH: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Stephan Haussig Herzzentrum , Conrad Rasmus Karl , Dennis Riedl , Protembis Gmb , Raj Makkar Cedars , Roxana Mehran Mount , Los Angeles , Protembis Gmbh , Study Executive Committee , Global Co , Boston Scientific , Superiority Trial , Demonstrate Effectiveness Against , Currently Approved Sentinel , Device Exemption , Pivotal Trial , New York Presbyterian Hospital , Cedars Sinai , Global Co Principal Investigators , Mount Sinai , Study Executive , Conrad Rasmus , Protection System , Rasmus Karl ,

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

NEW YORK & AACHEN, Germany, April 02, 2024 Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the enrollment of the first patient in the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). The trial will enroll between 250-500 randomized patients undergoing transcatheter aortic valve replacement (TAVR) in the USA and Europe with the ProtEmbo® System, an innovative next generation cerebral embolic protection devic ....

United States , Roxana Mehran Mount , Conrad Rasmus Karl , Raj Makkar Cedars , Los Angeles , Protembis Gmbh , Stephan Haussig Herzzentrum , Protembis Gmb , Global Co , Study Executive Committee , Boston Scientific , Superiority Trial , Demonstrate Effectiveness Against , Currently Approved Sentinel , Device Exemption , Pivotal Trial , New York Presbyterian Hospital , Cedars Sinai , Global Co Principal Investigators , Mount Sinai , Study Executive , Conrad Rasmus , Cerebral Protection System , Cerebral Protection ,

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Protembis Gmbh , Protembis Gmb , Azin Parhizgar , Keithd Dawkins , Dennis Riedl , Conrad Rasmus Karl , Ventric Health , Fulbright Scholar At Stanford University , British Cardiovascular Intervention Society , Jenavalve Technology Inc , Boston Scientific , Techvision Fund , Directors Builds Momentum , Device Exemption , Pivotal Trial , Sweden Based Segulah Medical Acceleration , Germany Based Techvision , Conrad Rasmus , Fulbright Scholar , Stanford University , Chief Medical Officer , Protembo System , Protection System , Rasmus Karl ,

Protembis Announces Completion of ? 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a ? 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE). ....

United States , United Kingdom , Azin Parhizgar , Keithd Dawkins , Protembis Gmbh , Boston Scientific , Product Service , British Cardiovascular Intervention Society , Techvision Fund , Ventric Health , Fulbright Scholar At Stanford University , Jenavalve Technology Inc , Announces Completion , Seriesb Financing Round , Device Exemption , Pivotal Trial , Sweden Based Segulah Medical Acceleration , Germany Based Techvision , Conrad Rasmus , Fulbright Scholar , Stanford University , Chief Medical Officer , Protembo System , Cerebral Protection System , Cerebral Protection ,